Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Wells syndrome is characterized by the presence of recurrent cellulitis-like eruptions with eosinophilia.
Biomarker and diagnostic research for Wells syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
1 clinical trial registered. Interventions under study include other interventions, medical devices, gene therapy, and biologic therapy. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
57 publications have been identified in PubMed for Wells syndrome. Research spans Case Report / Case Series (55%), Other (13%), and Review / Meta-Analysis (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 31 |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 11:53 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Wells syndrome
Other research | 7 | 13% |
Research summaries | 7 | 13% |
Laboratory research | 6 | 11% |
Disease patterns and progression | 2 | 4% |
Testing and diagnosis research | 1 | 2% |
Clinical study results | 1 | 2% |
New treatment approaches | 1 | 2% |
Alvi S (2026). [PMID: 41537014](https://pubmed.ncbi.nlm.nih.gov/41537014/). *JAAD Case Rep*. [Case Report / Case Series]
Stefanos L (2026). [PMID: 41912159](https://pubmed.ncbi.nlm.nih.gov/41912159/). *Dermatol Pract Concept*. [Other]
Yamada R (2026). [PMID: 41404858](https://pubmed.ncbi.nlm.nih.gov/41404858/). *J Dermatol*. [Other]
Kawata Y (2026). [PMID: 41075074](https://pubmed.ncbi.nlm.nih.gov/41075074/). *Clin J Gastroenterol*. [Case Report / Case Series]
Chessa MA (2026). [PMID: 41531022](https://pubmed.ncbi.nlm.nih.gov/41531022/). *J Dtsch Dermatol Ges*. [Epidemiology / Natural History]
Murchison M (2026). [PMID: 41623412](https://pubmed.ncbi.nlm.nih.gov/41623412/). *Am J Ophthalmol Case Rep*. [Case Report / Case Series]
Di Girolamo D (2026). [PMID: 41445194](https://pubmed.ncbi.nlm.nih.gov/41445194/). *Mol Ther*. [Gene Therapy / Novel Therapeutics]
Louka M (2026). [PMID: 41268802](https://pubmed.ncbi.nlm.nih.gov/41268802/). *Pediatr Dermatol*. [Case Report / Case Series]
Paulin MV (2026). [PMID: 42132225](https://pubmed.ncbi.nlm.nih.gov/42132225/). *J Vet Emerg Crit Care (San Antonio)*. [Case Report / Case Series]
Aslani N (2026). [PMID: 42163195](https://pubmed.ncbi.nlm.nih.gov/42163195/). *BMC Pediatr*. [Case Report / Case Series]